Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingnot_applicable

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

NCT06507748
recruiting

Therapeutic Endpoint in Pediatric IBD Conditions

NCT06065228
recruiting

Characterization of Acute Pain

NCT07336264

Clinical Trials (3)

Showing 3 of 3 trials
NCT06507748Not Applicable

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Recruiting
NCT06065228

Therapeutic Endpoint in Pediatric IBD Conditions

Recruiting
NCT07336264

Characterization of Acute Pain

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3